☰

Jonathan W. Mink - Publications

Affiliations: 
University of Rochester, Rochester, NY 
Area:
Motor System, Movement Disorders, Child Neurology, Batten Disease
Tree Info Grants Similar researchers PubMed Report error

148 high-probability publications. We are testing a new system for linking publications to authors. You can help! If you notice any inaccuracies, please sign in and mark papers as correct or incorrect matches. If you identify any major omissions or other inaccuracies in the publication list, please let us know.

Year Citation  Score
2024 Brima T, Freedman EG, Prinsloo KD, Augustine EF, Adams HR, Wang KH, Mink JW, Shaw LH, Mantel EP, Foxe JJ. Assessing the integrity of auditory sensory memory processing in CLN3 disease (Juvenile Neuronal Ceroid Lipofuscinosis (Batten disease)): an auditory evoked potential study of the duration-evoked mismatch negativity (MMN). Journal of Neurodevelopmental Disorders. 16: 3. PMID 38183037 DOI: 10.1186/s11689-023-09515-8  0.591
2023 Brima T, Freedman EG, Prinsloo KD, Augustine EF, Adams HR, Wang KH, Mink JW, Shaw LH, Mantel EP, Foxe JJ. Assessing the integrity of auditory sensory memory processing in CLN3 disease (Juvenile Neuronal Ceroid Lipofuscinosis (Batten disease)): An auditory evoked potential study of the duration-evoked mismatch negativity (MMN). Research Square. PMID 37645970 DOI: 10.21203/rs.3.rs-3203894/v1  0.583
2023 Lewin AB, Murphy TK, Mink JW, Small BJ, Adams HR, Brennan E, Augustine EF, Vermilion J, Vierhile A, Collins A, Kudryk K, Dickinson S, Danielson ML, Bitsko RH. Brief youth self-report screener for tics: Can a subscale of the Motor tic, Obsession and compulsion, and Vocal tic Evaluation Survey (MOVES) identify tic disorders in youth? Evidence-Based Practice in Child and Adolescent Mental Health. 8: 1-11. PMID 37323827 DOI: 10.1080/23794925.2023.2191354  0.605
2023 Sapozhnikov Y, Mink JW, Augustine EF, Adams HR, Vierhile A, Lewin AB, Collins AT, McDermott MP, O'Connor T, Kurlan R, Murphy TK, Vermilion J. Teacher Knowledge of Tourette Syndrome and Associated Factors. Pediatric Neurology. 145: 80-87. PMID 37295059 DOI: 10.1016/j.pediatrneurol.2023.05.007  0.525
2021 Vermilion J, Augustine EF, Adams HR, Vierhile A, Collins AT, McDermott MP, O'Connor TG, Kurlan R, van Wijngaarden E, Mink JW. Risk Behaviors in Youth With and Without Tourette Syndrome. Pediatric Neurology. 126: 20-25. PMID 34736059 DOI: 10.1016/j.pediatrneurol.2021.10.007  0.534
2021 Masten MC, Augustine EF, Mink JW. Challenges of Phenotype-Genotype Correlations in Rare Diseases. Jama Ophthalmology. 139: 1323. PMID 34709366 DOI: 10.1001/jamaophthalmol.2021.4372  0.577
2021 Masten MC, Corre C, Paciorkowski AR, Vierhile A, Adams HR, Vermilion J, Zimmerman GA, Augustine EF, Mink JW. A Diagnostic Confidence Scheme for CLN3 Disease. Journal of Inherited Metabolic Disease. PMID 34453334 DOI: 10.1002/jimd.12429  0.61
2021 Augustine EF, Adams HR, de Los Reyes E, Drago K, Frazier M, Guelbert N, Laine M, Levin T, Mink JW, Nickel M, Peifer D, Schulz A, Simonati A, Topcu M, Turunen JA, et al. Management of CLN1 Disease: International Clinical Consensus. Pediatric Neurology. 120: 38-51. PMID 34000449 DOI: 10.1016/j.pediatrneurol.2021.04.002  0.637
2021 Tang C, Han J, Dalvi S, Manian K, Winschel L, Volland S, Soto CA, Galloway CA, Spencer W, Roll M, Milliner C, Bonilha VL, Johnson TB, Latchney L, Weimer JM, ... ... Mink JW, et al. A human model of Batten disease shows role of CLN3 in phagocytosis at the photoreceptor-RPE interface. Communications Biology. 4: 161. PMID 33547385 DOI: 10.1038/s42003-021-01682-5  0.575
2020 Masten MC, Mink JW, Augustine EF. Batten disease: an expert update on agents in preclinical and clinical trials. Expert Opinion On Investigational Drugs. 1-6. PMID 33135495 DOI: 10.1080/13543784.2020.1837110  0.578
2020 Norris SA, Morris AE, Campbell MC, Karimi M, Babatunde A, Paniello RC, Snyder AZ, Petersen SE, Mink JW, Perlmutter JS. Regional, not global, functional connectivity contributes to isolated focal dystonia. Neurology. PMID 32913023 DOI: 10.1212/Wnl.0000000000010791  0.471
2020 Linden Hvd, Silveira-Moriyama L, Linden Vvd, Pessoa A, Valente K, Mink J, Paciorkowski A. Movement disorders in children with congenital Zika virus syndrome. Brain & Development. 42: 720-729. PMID 32682638 DOI: 10.1016/J.Braindev.2020.06.016  0.366
2020 Vermilion J, Pedraza C, Augustine EF, Adams HR, Vierhile A, Lewin AB, Collins AT, McDermott MP, O'Connor T, Kurlan R, van Wijngaarden E, Murphy TK, Mink JW. Anxiety Symptoms Differ in Youth With and Without Tic Disorders. Child Psychiatry and Human Development. PMID 32519083 DOI: 10.1007/S10578-020-01012-6  0.609
2020 Masten MC, Williams JD, Vermilion J, Adams HR, Vierhile A, Collins A, Marshall FJ, Augustine EF, Mink JW. The CLN3 disease staging system: A new tool for clinical research in Batten disease. Neurology. PMID 32300063 DOI: 10.1212/Wnl.0000000000009454  0.637
2020 Zimmerman G, Vierhile A, Adams H, Mink J, Augustine E. Methods for quantitative gait analysis in CLN3 disease Molecular Genetics and Metabolism. 129: S166. DOI: 10.1016/J.Ymgme.2019.11.444  0.618
2020 Mink JW, Masten MC, Vermilion J, Adams HR, Vierhile A, Marshall FJ, Beck CA, Augustine EF. Cross-sectional and longitudinal quantification of CLN3 disease progression Molecular Genetics and Metabolism. 129: S109-S110. DOI: 10.1016/J.Ymgme.2019.11.282  0.599
2020 Masten MC, Williams JD, Augustine EF, Vermilion J, Adams HR, Vierhile A, Thatcher A, Marshall FJ, Mink JW. The CLN3 Disease Staging System (CLN3SS): A tool for stratification based on disease severity Molecular Genetics and Metabolism. 129: S106. DOI: 10.1016/J.Ymgme.2019.11.271  0.626
2020 Masten MC, Vermilion J, Adams HR, Vierhile A, Marshall FJ, Beck CA, Augustine EF, Mink JW. Age-at-onset of core features of CLN3 disease: A cross-sectional and longitudinal natural history study Molecular Genetics and Metabolism. 129: S105-S106. DOI: 10.1016/J.Ymgme.2019.11.270  0.603
2020 Masten MC, Thatcher A, Bonifacio K, Vierhile A, Adams HR, Mink JW, Augustine EF. CLN1 disease natural history data: Prospective and retrospective analysis Molecular Genetics and Metabolism. 129: S105. DOI: 10.1016/J.Ymgme.2019.11.269  0.621
2020 Masten MC, Adams HR, Vierhile A, Augustine EF, Mink JW. Hamburg Late Infantile neuronal ceroid lipofucinosis scale (H-LINCLS) vs. the Unified Batten Disease Rating Scale (UBDRS): Comparison and cross-validation Molecular Genetics and Metabolism. 129: S105. DOI: 10.1016/J.Ymgme.2019.11.268  0.611
2020 Adams HR, Beck C, Bonifacio KP, Marshall FJ, Masten M, Thatcher A, Vermilion J, Vierhile A, Augustine EF, Mink JW. Cross-validation of the Vineland-III with independent assessments of cognition and adaptive skills in CLN3 disease Molecular Genetics and Metabolism. 129: S17-S18. DOI: 10.1016/J.Ymgme.2019.11.014  0.603
2019 Vermilion J, Augustine E, Adams HR, Vierhile A, Lewin AB, Thatcher A, McDermott MP, O'Connor T, Kurlan R, van Wijngaarden E, Murphy TK, Mink JW. Tic Disorders are Associated With Lower Child and Parent Quality of Life and Worse Family Functioning. Pediatric Neurology. PMID 32029331 DOI: 10.1016/J.Pediatrneurol.2019.12.003  0.609
2019 Yilmaz S, Mink JW. Treatment of Chorea in Childhood. Pediatric Neurology. PMID 31604647 DOI: 10.1016/J.Pediatrneurol.2019.08.013  0.324
2019 Vermilion J, Johnson M, Srinivasan J, Mink JW. Neuronal Intranuclear Inclusion Disease: Longitudinal Case Report of Motor and Nonmotor Symptoms. Journal of Child Neurology. 883073819860566. PMID 31304825 DOI: 10.1177/0883073819860566  0.378
2019 Adams HR, Defendorf S, Vierhile A, Mink JW, Marshall FJ, Augustine EF. A novel, hybrid, single- and multi-site clinical trial design for CLN3 disease, an ultra-rare lysosomal storage disorder. Clinical Trials (London, England). 1740774519855715. PMID 31184505 DOI: 10.1177/1740774519855715  0.632
2019 Bitsko R, Adams HR, Holbrook J, Jones C, Augustine E, Mink J, Wijngaarden Ev, Vierhile A, Morrison P, Fisher PW. 2.50 DIAGNOSTIC INTERVIEW SCHEDULE FOR CHILDREN, VERSION 5 (DISC-5): DEVELOPMENT AND VALIDATION OF ADHD AND TIC DISORDER MODULES Journal of the American Academy of Child & Adolescent Psychiatry. 58: S187. DOI: 10.1016/J.Jaac.2019.08.142  0.605
2018 Mink JW. Natural history data for childhood neurodegenerative disease. The Lancet. Child & Adolescent Health. 2: 547-548. PMID 30119709 DOI: 10.1016/S2352-4642(18)30210-4  0.321
2018 Augustine EF, Beck CA, Adams HR, Defendorf S, Vierhile A, Timm D, Weimer JM, Mink JW, Marshall FJ. Short-Term Administration of Mycophenolate Is Well-Tolerated in CLN3 Disease (Juvenile Neuronal Ceroid Lipofuscinosis). Jimd Reports. PMID 29923092 DOI: 10.1007/8904_2018_113  0.593
2018 Morris AE, Norris SA, Perlmutter JS, Mink JW. Quantitative, clinically relevant acoustic measurements of focal embouchure dystonia. Movement Disorders : Official Journal of the Movement Disorder Society. PMID 29460980 DOI: 10.1002/Mds.27298  0.495
2018 Mink JW, Williams JD, Augustine EF. A proposed staging system for CLN3 disease (juvenile Batten disease) Molecular Genetics and Metabolism. 123: S96. DOI: 10.1016/J.Ymgme.2017.12.251  0.619
2018 Adams HR, Mink J, Augustine E, Bitsko RH, Holbrook J, Vierhile A, Morrison P, Bonifacio K, vanWijngaarden E. 36.2 Improving Identification of Tic Disorders Journal of the American Academy of Child & Adolescent Psychiatry. 57: S326. DOI: 10.1016/J.Jaac.2018.07.825  0.601
2017 Vermilion J, Mink JW. Pearls & Oy-sters: Frontal lobe epilepsy presenting as complex stereotyped movements. Neurology. 89: e124-e125. PMID 28871070 DOI: 10.1212/Wnl.0000000000004339  0.323
2017 Augustine EF, Adams HR, Mink JW. Screening tools for tic disorders-Focus on development or implementation? Movement Disorders : Official Journal of the Movement Disorder Society. PMID 28436544 DOI: 10.1002/Mds.26981  0.587
2017 Williams RE, Adams HR, Blohm M, Cohen-Pfeffer JL, de Los Reyes E, Denecke J, Drago K, Fairhurst C, Frazier M, Guelbert N, Kiss S, Kofler A, Lawson JA, Lehwald L, Leung MA, ... ... Mink JW, et al. Management Strategies for CLN2 Disease. Pediatric Neurology. 69: 102-112. PMID 28335910 DOI: 10.1016/J.Pediatrneurol.2017.01.034  0.345
2017 Cozart EJ, Augustine EF, Mink JW, Thatcher AR, Adams HR. Batten disease and parents: marital quality, support, and communication Journal of International Child Neurology Association. DOI: 10.17724/Jicna.2017.114  0.61
2016 Dhamija R, Mink JW, Shah BB, Goodkin HP. -Associated Movement Disorder. Movement Disorders Clinical Practice. 3: 615-617. PMID 30838255 DOI: 10.1002/Mdc3.12344  0.56
2016 Augustine EF, Adams HR, Bitsko RH, van Wijngaarden E, Claussen AH, Thatcher A, Hanks CE, Lewin AB, O'Connor TG, Vierhile A, Danielson ML, Kurlan R, Murphy TK, Mink JW. Design of a Multisite Study Assessing the Impact of Tic Disorders on Individuals, Families, and Communities. Pediatric Neurology. PMID 28254245 DOI: 10.1016/J.Pediatrneurol.2016.10.017  0.618
2016 Augustine EF, Mink JW. Juvenile NCL (CLN3 Disease): Emerging Disease-Modifying Therapeutic Strategies. Pediatric Endocrinology Reviews : Per. 13: 655-62. PMID 27491213  0.602
2016 Jaynes MJ, Schieber MH, Mink JW. Temporal and kinematic consistency predict sequence awareness. Experimental Brain Research. PMID 27324192 DOI: 10.1007/S00221-016-4704-7  0.577
2016 Koy A, Lin JP, Sanger TD, Marks WA, Mink JW, Timmermann L. Advances in management of movement disorders in children. The Lancet. Neurology. 15: 719-35. PMID 27302239 DOI: 10.1016/S1474-4422(16)00132-0  0.36
2016 Deeb W, Rossi PJ, Porta M, Visser-Vandewalle V, Servello D, Silburn P, Coyne T, Leckman JF, Foltynie T, Hariz M, Joyce EM, Zrinzo L, Kefalopoulou Z, Welter ML, Karachi C, ... ... Mink JW, et al. The International Deep Brain Stimulation Registry and Database for Gilles de la Tourette Syndrome: How Does It Work? Frontiers in Neuroscience. 10: 170. PMID 27199634 DOI: 10.3389/Fnins.2016.00170  0.339
2016 McGuire J, Hanks CE, Mink JW, Adams HR, Augustine EF, Vierhile AE, Thatcher A, Lewin AB, Murphy TK. 1.1 Suicidal Thoughts and Behaviors in Children and Adolescents With Chronic Tic Disorders Journal of the American Academy of Child and Adolescent Psychiatry. 55. DOI: 10.1016/J.Jaac.2016.07.120  0.598
2016 Andrzejewski K, Barbano R, Mink J. Cannabinoids in the treatment of movement disorders: A systematic review of case series and clinical trials Basal Ganglia. 6: 173-181. DOI: 10.1016/J.Baga.2016.06.001  0.353
2015 Ragbeer SN, Augustine EF, Mink JW, Thatcher AR, Vierhile AE, Adams HR. Remote Assessment of Cognitive Function in Juvenile Neuronal Ceroid Lipofuscinosis (Batten disease): A Pilot Study of Feasibility and Reliability. Journal of Child Neurology. PMID 26336202 DOI: 10.1177/0883073815600863  0.638
2015 Ricketts EJ, Gilbert DL, Zinner SH, Mink JW, Lipps TD, Wiegand GA, Vierhile AE, Ely LJ, Piacentini J, Walkup JT, Woods DW. Pilot Testing Behavior Therapy for Chronic Tic Disorders in Neurology and Developmental Pediatrics Clinics. Journal of Child Neurology. PMID 26271790 DOI: 10.1177/0883073815599257  0.33
2015 Mink JW. Treatment of paroxysmal dyskinesias in children. Current Treatment Options in Neurology. 17: 350. PMID 25864940 DOI: 10.1007/S11940-015-0350-9  0.311
2015 Storch EA, Hanks CE, Mink JW, McGuire JF, Adams HR, Augustine EF, Vierhile A, Thatcher A, Bitsko R, Lewin AB, Murphy TK. SUICIDAL THOUGHTS AND BEHAVIORS IN CHILDREN AND ADOLESCENTS WITH CHRONIC TIC DISORDERS. Depression and Anxiety. PMID 25711415 DOI: 10.1002/Da.22357  0.619
2015 Schrock LE, Mink JW, Woods DW, Porta M, Servello D, Visser-Vandewalle V, Silburn PA, Foltynie T, Walker HC, Shahed-Jimenez J, Savica R, Klassen BT, Machado AG, Foote KD, Zhang JG, et al. Tourette syndrome deep brain stimulation: a review and updated recommendations. Movement Disorders : Official Journal of the Movement Disorder Society. 30: 448-71. PMID 25476818 DOI: 10.1002/Mds.26094  0.32
2015 Augustine EF, Adams HR, Beck CA, Vierhile A, Kwon J, Rothberg PG, Marshall F, Block R, Dolan J, Mink JW. Standardized assessment of seizures in patients with juvenile neuronal ceroid lipofuscinosis. Developmental Medicine and Child Neurology. 57: 366-71. PMID 25387857 DOI: 10.1111/Dmcn.12634  0.595
2014 Black KJ, Jankovic J, Hershey T, McNaught KS, Mink JW, Walkup J. Progress in research on Tourette syndrome. Journal of Obsessive-Compulsive and Related Disorders. 3: 359-362. PMID 25436182 DOI: 10.1016/J.Jocrd.2014.03.005  0.676
2014 Dugan LL, Tian L, Quick KL, Hardt JI, Karimi M, Brown C, Loftin S, Flores H, Moerlein SM, Polich J, Tabbal SD, Mink JW, Perlmutter JS. Carboxyfullerene neuroprotection postinjury in Parkinsonian nonhuman primates. Annals of Neurology. 76: 393-402. PMID 25043598 DOI: 10.1002/Ana.24220  0.455
2014 Lewin AB, Mink JW, Bitsko RH, Holbrook JR, Parker-Athill EC, Hanks C, Storch EA, Augustine EF, Adams HR, Vierhile AE, Thatcher AR, Murphy TK. Utility of the diagnostic interview schedule for children for assessing Tourette syndrome in children. Journal of Child and Adolescent Psychopharmacology. 24: 275-84. PMID 24813854 DOI: 10.1089/Cap.2013.0128  0.61
2014 Mink JW. The impact of development on the interpretation of movement disorders rating scales. Developmental Medicine and Child Neurology. 56: 511-2. PMID 24725052 DOI: 10.1111/Dmcn.12464  0.301
2014 Black KJ, Snyder AZ, Mink JW, Tolia VN, Revilla FJ, Moerlein SM, Perlmutter JS. Spatial reorganization of putaminal dopamine D2-like receptors in cranial and hand dystonia. Plos One. 9: e88121. PMID 24520350 DOI: 10.1371/Journal.Pone.0088121  0.629
2014 Adams HR, Rose K, Augustine EF, Kwon JM, deBlieck EA, Marshall FJ, Vierhile A, Mink JW, Nance MA. Experience, knowledge, and opinions about childhood genetic testing in Batten disease. Molecular Genetics and Metabolism. 111: 197-202. PMID 24246680 DOI: 10.1016/J.Ymgme.2013.10.017  0.616
2014 Black KJ, Snyder AZ, Mink JW, Tolia VN, Revilla FJ, Moerlein SM, Perlmutter JS. Mean location in atlas space of peak [ 18 F]spiperone binding, by group (mm). Plos One. DOI: 10.1371/Journal.Pone.0088121.T001  0.6
2014 Black KJ, Snyder AZ, Mink JW, Tolia VN, Revilla FJ, Moerlein SM, Perlmutter JS. Coronal view of peak [ 18 F]spiperone binding in striatum in cranial and hand dystonia. Plos One. DOI: 10.1371/Journal.Pone.0088121.G002  0.608
2014 Mink JW. Movement disorders differ in different forms of neuronal ceroid lipofusinosis Molecular Genetics and Metabolism. 111: S77. DOI: 10.1016/J.Ymgme.2013.12.179  0.322
2014 Defendorf S, Adams H, Augustine E, Mink J, Marshall F, Vierhile A. The challenges of clinical trials in rare disease: lessons from Batten disease Molecular Genetics and Metabolism. 111: S35. DOI: 10.1016/J.Ymgme.2013.12.065  0.636
2013 Tully HM, Dempsey JC, Ishak GE, Adam MP, Mink JW, Dobyns WB, Gospe SM, Weiss A, Phillips JO, Doherty D. Persistent figure-eight and side-to-side head shaking is a marker for rhombencephalosynapsis. Movement Disorders : Official Journal of the Movement Disorder Society. 28: 2019-23. PMID 24105968 DOI: 10.1002/Mds.25634  0.309
2013 Augustine EF, Adams HR, Mink JW. Clinical trials in rare disease: challenges and opportunities. Journal of Child Neurology. 28: 1142-50. PMID 24014509 DOI: 10.1177/0883073813495959  0.652
2013 Adams HR, Mink JW. Neurobehavioral features and natural history of juvenile neuronal ceroid lipofuscinosis (Batten disease). Journal of Child Neurology. 28: 1128-36. PMID 24014508 DOI: 10.1177/0883073813494813  0.365
2013 Augustine EF, Mink JW. Enzyme replacement in neuronal storage disorders in the pediatric population. Current Treatment Options in Neurology. 15: 634-51. PMID 23955157 DOI: 10.1007/S11940-013-0256-3  0.65
2013 Mink JW. Special concerns in defining, studying, and treating dystonia in children. Movement Disorders : Official Journal of the Movement Disorder Society. 28: 921-5. PMID 23893449 DOI: 10.1002/Mds.25548  0.333
2013 Dolisca SB, Mehta M, Pearce DA, Mink JW, Maria BL. Batten disease: clinical aspects, molecular mechanisms, translational science, and future directions. Journal of Child Neurology. 28: 1074-100. PMID 23838031 DOI: 10.1177/0883073813493665  0.389
2013 Mink JW, Augustine EF, Adams HR, Marshall FJ, Kwon JM. Classification and natural history of the neuronal ceroid lipofuscinoses. Journal of Child Neurology. 28: 1101-5. PMID 23838030 DOI: 10.1177/0883073813494268  0.641
2013 Augustine EF, Blackburn J, Pellegrino JE, Miller R, Mink JW. Myoclonus-dystonia syndrome associated with Russell Silver syndrome. Movement Disorders : Official Journal of the Movement Disorder Society. 28: 841-2. PMID 23703955 DOI: 10.1002/Mds.25483  0.626
2013 Albanese A, Bhatia K, Bressman SB, Delong MR, Fahn S, Fung VS, Hallett M, Jankovic J, Jinnah HA, Klein C, Lang AE, Mink JW, Teller JK. Phenomenology and classification of dystonia: a consensus update. Movement Disorders : Official Journal of the Movement Disorder Society. 28: 863-73. PMID 23649720 DOI: 10.1002/Mds.25475  0.346
2013 de Blieck EA, Augustine EF, Marshall FJ, Adams H, Cialone J, Dure L, Kwon JM, Newhouse N, Rose K, Rothberg PG, Vierhile A, Mink JW. Methodology of clinical research in rare diseases: development of a research program in juvenile neuronal ceroid lipofuscinosis (JNCL) via creation of a patient registry and collaboration with patient advocates. Contemporary Clinical Trials. 35: 48-54. PMID 23628560 DOI: 10.1016/J.Cct.2013.04.004  0.654
2013 Schulz A, Kohlschütter A, Mink J, Simonati A, Williams R. NCL diseases - clinical perspectives. Biochimica Et Biophysica Acta. 1832: 1801-6. PMID 23602993 DOI: 10.1016/J.Bbadis.2013.04.008  0.38
2013 Okun MS, Foote KD, Wu SS, Ward HE, Bowers D, Rodriguez RL, Malaty IA, Goodman WK, Gilbert DM, Walker HC, Mink JW, Merritt S, Morishita T, Sanchez JC. A trial of scheduled deep brain stimulation for Tourette syndrome: moving away from continuous deep brain stimulation paradigms. Jama Neurology. 70: 85-94. PMID 23044532 DOI: 10.1001/Jamaneurol.2013.580  0.342
2013 Gordon M, Cologne SE, Hartlein JM, Koller J, Schlaggar BL, Mink JW, Black KJ. A pilot study of levodopa for treatment of tics in children and adults F1000research. 4. DOI: 10.7490/F1000Research.1093664.1  0.526
2013 Mink J, Augustine EF, Marshall FJ, Adams HR, Kwon JM, Vierhile A, de Blieck EA. The natural history of juvenile Batten disease (JNCL; CLN3 disease) Molecular Genetics and Metabolism. 108: S66. DOI: 10.1016/J.Ymgme.2012.11.170  0.632
2012 Blackburn JS, Mink JW, Augustine EF. Pediatric movement disorders: Five new things. Neurology. Clinical Practice. 2: 311-318. PMID 23634375 DOI: 10.1212/CPJ.0b013e318278bf06  0.622
2012 Brashear A, Mink JW, Hill DF, Boggs N, McCall WV, Stacy MA, Snively B, Light LS, Sweadner KJ, Ozelius LJ, Morrison L. ATP1A3 mutations in infants: a new rapid-onset dystonia-Parkinsonism phenotype characterized by motor delay and ataxia. Developmental Medicine and Child Neurology. 54: 1065-7. PMID 22924536 DOI: 10.1111/J.1469-8749.2012.04421.X  0.304
2012 Cialone J, Adams H, Augustine EF, Marshall FJ, Kwon JM, Newhouse N, Vierhile A, Levy E, Dure LS, Rose KR, Ramirez-Montealegre D, de Blieck EA, Mink JW. Females experience a more severe disease course in Batten disease. Journal of Inherited Metabolic Disease. 35: 549-55. PMID 22167274 DOI: 10.1007/S10545-011-9421-6  0.644
2012 Augustine E, Newhouse N, Adams H, Vierhile A, Kwon J, Marshall F, Mink J. Epilepsy in Juvenile Neuronal Ceroid Lipofuscinosis is Usually Characterized by Well- Controlled Generalized Tonic-Clonic Seizures Molecular Genetics and Metabolism. 105: S18-S19. DOI: 10.1016/J.Ymgme.2011.11.021  0.582
2012 Adams H, Augustine E, Potter S, Kwon J, Marshall F, Newhouse N, Vierhile A, Mink J. Medical Comorbidities in Juvenile Neuronal Ceroid Lipofuscinosis (Batten Disease) Molecular Genetics and Metabolism. 105: S15. DOI: 10.1016/J.Ymgme.2011.11.009  0.646
2012 Cialone J, Adams H, Augustine EF, Marshall FJ, Kwon JM, Newhouse N, Vierhile A, Levy E, Dure LS, Rose KR, Ramirez-Montealegre D, de Blieck EA, Mink JW. Erratum to: Females experience a more severe disease course in batten disease Journal of Inherited Metabolic Disease. 35: 559-559. DOI: 10.1007/S10545-011-9442-1  0.623
2011 McNaught KS, Mink JW. Advances in understanding and treatment of Tourette syndrome. Nature Reviews. Neurology. 7: 667-76. PMID 22064610 DOI: 10.1038/Nrneurol.2011.167  0.354
2011 Cialone J, Augustine EF, Newhouse N, Vierhile A, Marshall FJ, Mink JW. Quantitative telemedicine ratings in Batten disease: implications for rare disease research. Neurology. 77: 1808-11. PMID 22013181 DOI: 10.1212/Wnl.0B013E3182377E29  0.622
2011 Kwon JM, Adams H, Rothberg PG, Augustine EF, Marshall FJ, Deblieck EA, Vierhile A, Beck CA, Newhouse NJ, Cialone J, Levy E, Ramirez-Montealegre D, Dure LS, Rose KR, Mink JW. Quantifying physical decline in juvenile neuronal ceroid lipofuscinosis (Batten disease). Neurology. 77: 1801-7. PMID 22013180 DOI: 10.1212/Wnl.0B013E318237F649  0.645
2011 Cialone J, Augustine EF, Newhouse N, Adams H, Vierhile A, Marshall FJ, de Blieck EA, Kwon J, Rothberg PG, Mink JW. Parent-reported benefits of flupirtine in juvenile neuronal ceroid lipofuscinosis (Batten disease; CLN3) are not supported by quantitative data. Journal of Inherited Metabolic Disease. 34: 1075-81. PMID 21556831 DOI: 10.1007/S10545-011-9346-0  0.662
2011 Mink J, Kurlan R. Acute postinfectious movement and psychiatric disorders in children and adolescents Journal of Child Neurology. 26: 214-217. PMID 21098332 DOI: 10.1177/0883073810378534  0.317
2011 Mink J, Augustine EF, Adams H, Newhouse NJ, Vierhile A, deBlieck EA, Cialone J, Marshall FJ. A phase II, randomized, controlled trial of Mycophenolate Mofetil in children with juvenile NCL (JNCL) Molecular Genetics and Metabolism. 102: S30. DOI: 10.1016/J.Ymgme.2010.11.100  0.585
2011 Adams H, Augustine E, Cialone J, Newhouse N, Vierhile A, deBlieck E, Marshall F, Mink J, Kwon J, Rothberg P. Sex differences in clinical progression and quality of life in juvenile neuronal ceroid lipofuscinosis Molecular Genetics and Metabolism. 102: S3. DOI: 10.1016/J.Ymgme.2010.11.008  0.601
2010 Mink JW, Zinner SH. Movement disorders ii: chorea, dystonia, myoclonus, and tremor. Pediatrics in Review / American Academy of Pediatrics. 31: 287-94; quiz 295. PMID 20595442 DOI: 10.1542/Pir.31-7-287  0.349
2010 Sanger TD, Chen D, Fehlings DL, Hallett M, Lang AE, Mink JW, Singer HS, Alter K, Ben-Pazi H, Butler EE, Chen R, Collins A, Dayanidhi S, Forssberg H, Fowler E, et al. Definition and classification of hyperkinetic movements in childhood. Movement Disorders : Official Journal of the Movement Disorder Society. 25: 1538-49. PMID 20589866 DOI: 10.1002/Mds.23088  0.336
2010 Zinner SH, Mink JW. Movement disorders I: tics and stereotypies. Pediatrics in Review / American Academy of Pediatrics. 31: 223-33. PMID 20516234 DOI: 10.1542/Pir.31-6-223  0.356
2010 Adams HR, Beck CA, Levy E, Jordan R, Kwon JM, Marshall FJ, Vierhile A, Augustine EF, de Blieck EA, Pearce DA, Mink JW. Genotype does not predict severity of behavioural phenotype in juvenile neuronal ceroid lipofuscinosis (Batten disease). Developmental Medicine and Child Neurology. 52: 637-43. PMID 20187884 DOI: 10.1111/J.1469-8749.2010.03628.X  0.636
2010 Kaufman CB, Mink JW, Schwalb JM. Bilateral deep brain stimulation for treatment of medically refractory paroxysmal nonkinesigenic dyskinesia. Journal of Neurosurgery. 112: 847-50. PMID 19799495 DOI: 10.3171/2009.9.Jns09454  0.335
2010 Mink J, Kwon JM, Marshall FJ, Adams HR, Rothberg PG, deBlieck EA, Vierhile A, Newhouse NJ, Levy EJ, Augustine EF, Ramirez-Montealegre D. 94. The UBDRS predicts rate of JCNL (CLN3) disease progression Molecular Genetics and Metabolism. 99: S27. DOI: 10.1016/J.Ymgme.2009.10.111  0.612
2010 Adams H, Newhouse NJ, Levy EJ, Mink JW, Kwon JM, Marshall FJ, de Blieck E, Vierhile A, Augustine EF, Ramirez-Montealegre D, Adams HR. 2. Visual aid skills and socioeconomic status in children with Batten disease Molecular Genetics and Metabolism. 99: S8. DOI: 10.1016/J.Ymgme.2009.10.019  0.662
2010 Adams H, Newhouse N, Levy EJ, Kwon JM, Marshall FJ, deBlieck EA, Vierhile A, Augustine EF, Ramirez D, Mink JW. 1. Update on longitudinal assessment of children with juvenile neuronal ceroid lipofuscinosis (Batten disease) Molecular Genetics and Metabolism. 99: S8. DOI: 10.1016/J.Ymgme.2009.10.018  0.633
2009 Mink JW. Movement disorders. Introduction. Seminars in Pediatric Neurology. 16: 59. PMID 19501332 DOI: 10.1016/J.Spen.2009.04.002  0.304
2009 Mink J. 92. Longitudinal studies in Batten disease Molecular Genetics and Metabolism. 96: S32. DOI: 10.1016/J.Ymgme.2008.11.093  0.328
2008 Karimi M, Golchin N, Tabbal SD, Hershey T, Videen TO, Wu J, Usche JW, Revilla FJ, Hartlein JM, Wernle AR, Mink JW, Perlmutter JS. Subthalamic nucleus stimulation-induced regional blood flow responses correlate with improvement of motor signs in Parkinson disease. Brain : a Journal of Neurology. 131: 2710-9. PMID 18697909 DOI: 10.1093/Brain/Awn179  0.668
2008 Tabbal SD, Ushe M, Mink JW, Revilla FJ, Wernle AR, Hong M, Karimi M, Perlmutter JS. Unilateral subthalamic nucleus stimulation has a measurable ipsilateral effect on rigidity and bradykinesia in Parkinson disease. Experimental Neurology. 211: 234-42. PMID 18329019 DOI: 10.1016/J.Expneurol.2008.01.024  0.778
2008 Sanger TD, Bastian A, Brunstrom J, Damiano D, Delgado M, Dure L, Gaebler-Spira D, Hoon A, Mink JW, Sherman-Levine S, Welty LJ. Response to correspondence on "Prospective open-label clinical trial of trihexyphenidyl in children with secondary dystonia due to cerebral palsy" Journal of Child Neurology. 23: 846-847. DOI: 10.1177/0883073808316371  0.549
2008 Kwon J, Marshall F, Adams H, Rothberg P, Vierhile A, deBlieck E, Pearce D, Mink J. 57. Quantifying the rate of neurologic decline in Batten disease in clinical trials Molecular Genetics and Metabolism. 93: 28. DOI: 10.1016/J.Ymgme.2007.10.069  0.319
2007 Tabbal SD, Revilla FJ, Mink JW, Schneider-Gibson P, Wernle AR, de Erausquin GA, Perlmutter JS, Rich KM, Dowling JL. Safety and efficacy of subthalamic nucleus deep brain stimulation performed with limited intraoperative mapping for treatment of Parkinson's disease. Neurosurgery. 61: 119-27; discussion 1. PMID 17876242 DOI: 10.1227/01.Neu.0000289725.97211.51  0.525
2007 Adams HR, Kwon J, Marshall FJ, de Blieck EA, Pearce DA, Mink JW. Neuropsychological symptoms of juvenile-onset batten disease: experiences from 2 studies. Journal of Child Neurology. 22: 621-7. PMID 17690071 DOI: 10.1177/0883073807302603  0.362
2007 Sanger TD, Bastian A, Brunstrom J, Damiano D, Delgado M, Dure L, Gaebler-Spira D, Hoon A, Mink JW, Sherman-Levine S, Welty LJ. Prospective open-label clinical trial of trihexyphenidyl in children with secondary dystonia due to cerebral palsy. Journal of Child Neurology. 22: 530-7. PMID 17690057 DOI: 10.1177/0883073807302601  0.581
2006 Sanger TD, Chen D, Delgado MR, Gaebler-Spira D, Hallett M, Mink JW. Definition and classification of negative motor signs in childhood. Pediatrics. 118: 2159-67. PMID 17079590 DOI: 10.1542/Peds.2005-3016  0.319
2006 Mink JW, Walkup J, Frey KA, Como P, Cath D, Delong MR, Erenberg G, Jankovic J, Juncos J, Leckman JF, Swerdlow N, Visser-Vandewalle V, Vitek JL. Patient selection and assessment recommendations for deep brain stimulation in Tourette syndrome. Movement Disorders : Official Journal of the Movement Disorder Society. 21: 1831-8. PMID 16991144 DOI: 10.1002/Mds.21039  0.315
2006 Perlmutter JS, Mink JW. Deep brain stimulation. Annual Review of Neuroscience. 29: 229-57. PMID 16776585 DOI: 10.1146/Annurev.Neuro.29.051605.112824  0.524
2006 Tabbal SD, Mink JW, Antenor JA, Carl JL, Moerlein SM, Perlmutter JS. 1-Methyl-4-phenyl-1,2,3,6-tetrahydropyridine-induced acute transient dystonia in monkeys associated with low striatal dopamine. Neuroscience. 141: 1281-7. PMID 16766129 DOI: 10.1016/J.Neuroscience.2006.04.072  0.462
2006 Ushe M, Mink JW, Tabbal SD, Hong M, Schneider Gibson P, Rich KM, Lyons KE, Pahwa R, Perlmutter JS. Postural tremor suppression is dependent on thalamic stimulation frequency. Movement Disorders : Official Journal of the Movement Disorder Society. 21: 1290-2. PMID 16685684 DOI: 10.1002/Mds.20926  0.759
2006 Weiss EM, Hershey T, Karimi M, Racette B, Tabbal SD, Mink JW, Paniello RC, Perlmutter JS. Relative risk of spread of symptoms among the focal onset primary dystonias. Movement Disorders : Official Journal of the Movement Disorder Society. 21: 1175-81. PMID 16673404 DOI: 10.1002/Mds.20919  0.709
2006 Hershey T, Mink JW. Using functional neuroimaging to study the brain's response to deep brain stimulation. Neurology. 66: 1142-3. PMID 16636228 DOI: 10.1212/01.Wnl.0000216425.34178.Dd  0.563
2006 Mink JW. Abnormal circuit function in dystonia. Neurology. 66: 959. PMID 16610101 DOI: 10.1212/01.Wnl.0000215937.63781.9A  0.308
2006 Albin RL, Mink JW. Recent advances in Tourette syndrome research. Trends in Neurosciences. 29: 175-82. PMID 16430974 DOI: 10.1016/J.Tins.2006.01.001  0.307
2005 Yang ML, Fullwood E, Goldstein J, Mink JW. Masturbation in infancy and early childhood presenting as a movement disorder: 12 cases and a review of the literature. Pediatrics. 116: 1427-32. PMID 16322167 DOI: 10.1542/Peds.2005-0532  0.342
2005 Kwon JM, Rothberg PG, Leman AR, Weimer JM, Mink JW, Pearce DA. Novel CLN3 mutation predicted to cause complete loss of protein function does not modify the classical JNCL phenotype. Neuroscience Letters. 387: 111-4. PMID 16087292 DOI: 10.1016/J.Neulet.2005.07.023  0.323
2005 Marshall FJ, de Blieck EA, Mink JW, Dure L, Adams H, Messing S, Rothberg PG, Levy E, McDonough T, DeYoung J, Wang M, Ramirez-Montealegre D, Kwon JM, Pearce DA. A clinical rating scale for Batten disease: reliable and relevant for clinical trials. Neurology. 65: 275-9. PMID 16043799 DOI: 10.1212/01.Wnl.0000169019.41332.8A  0.372
2004 Ushe M, Mink JW, Revilla FJ, Wernle A, Schneider Gibson P, McGee-Minnich L, Hong M, Rich KM, Lyons KE, Pahwa R, Perlmutter JS. Effect of stimulation frequency on tremor suppression in essential tremor. Movement Disorders : Official Journal of the Movement Disorder Society. 19: 1163-8. PMID 15390071 DOI: 10.1002/Mds.20231  0.766
2004 Kirsch DB, Mink JW. Psychogenic movement disorders in children. Pediatric Neurology. 30: 1-6. PMID 14738942 DOI: 10.1016/J.Pediatrneurol.2003.07.001  0.339
2004 Perlmutter JS, Mink JW. Dysfunction of dopaminergic pathways in dystonia. Advances in Neurology. 94: 163-70. PMID 14509670  0.387
2003 Mink JW. The Basal Ganglia and involuntary movements: impaired inhibition of competing motor patterns. Archives of Neurology. 60: 1365-8. PMID 14568805 DOI: 10.1001/Archneur.60.10.1365  0.316
2003 Mink JW, Caruso PA, Pomeroy SL. Progressive myoclonus in a child with a deep cerebellar mass. Neurology. 61: 829-31. PMID 14504331 DOI: 10.1212/01.Wnl.0000082441.97535.Ed  0.313
2003 Hershey T, Revilla FJ, Wernle AR, McGee-Minnich L, Antenor JV, Videen TO, Dowling JL, Mink JW, Perlmutter JS. Cortical and subcortical blood flow effects of subthalamic nucleus stimulation in PD. Neurology. 61: 816-21. PMID 14504327 DOI: 10.1212/01.Wnl.0000083991.81859.73  0.652
2003 Bastian AJ, Kelly VE, Perlmutter JS, Mink JW. Effects of pallidotomy and levodopa on walking and reaching movements in Parkinson's disease. Movement Disorders : Official Journal of the Movement Disorder Society. 18: 1008-17. PMID 14502668 DOI: 10.1002/Mds.10494  0.678
2003 Bastian AJ, Kelly VE, Revilla FJ, Perlmutter JS, Mink JW. Different effects of unilateral versus bilateral subthalamic nucleus stimulation on walking and reaching in Parkinson's disease. Movement Disorders : Official Journal of the Movement Disorder Society. 18: 1000-7. PMID 14502667 DOI: 10.1002/Mds.10493  0.68
2003 Schlaggar BL, Mink JW. Movement disorders in children. Pediatrics in Review / American Academy of Pediatrics. 24: 39-51. PMID 12563038 DOI: 10.1542/Pir.24-2-39  0.35
2003 Sanger TD, Delgado MR, Gaebler-Spira D, Hallett M, Mink JW. Classification and definition of disorders causing hypertonia in childhood. Pediatrics. 111: e89-97. PMID 12509602 DOI: 10.1542/Peds.111.1.E89  0.34
2002 Racette BA, Hartlein JM, Hershey T, Mink JW, Perlmutter JS, Black KJ. Clinical features and comorbidity of mood fluctuations in Parkinson's disease. The Journal of Neuropsychiatry and Clinical Neurosciences. 14: 438-42. PMID 12426412 DOI: 10.1176/Jnp.14.4.438  0.788
2002 Mink JW, McKinstry RC. Volumetric MRI in autism: can high-tech craniometry provide neurobiological insights? Neurology. 59: 158-9. PMID 12136049 DOI: 10.1212/Wnl.59.2.158  0.301
2002 Perlmutter JS, Mink JW, Bastian AJ, Zackowski K, Hershey T, Miyawaki E, Koller W, Videen TO. Blood flow responses to deep brain stimulation of thalamus. Neurology. 58: 1388-94. PMID 12011286 DOI: 10.1212/Wnl.58.9.1388  0.726
2002 Zackowski KM, Bastian AJ, Hakimian S, Mink JW, Perlmutter JS, Koller WC, Thach WT. Thalamic stimulation reduces essential tremor but not the delayed antagonist muscle timing. Neurology. 58: 402-10. PMID 11839839 DOI: 10.1212/Wnl.58.3.402  0.74
2001 Mink JW. Basal ganglia motor function in relation to Hallervorden-Spatz syndrome. Pediatric Neurology. 25: 112-7. PMID 11551741 DOI: 10.1016/S0887-8994(01)00270-3  0.347
2001 Racette BA, Dowling J, Randle J, Mink JW. Thalamic stimulation for primary writing tremor. Journal of Neurology. 248: 380-2. PMID 11437158 DOI: 10.1007/S004150170177  0.558
2001 Racette BA, McGee-Minnich L, Moerlein SM, Mink JW, Videen TO, Perlmutter JS. Welding-related parkinsonism: clinical features, treatment, and pathophysiology. Neurology. 56: 8-13. PMID 11148228 DOI: 10.1212/Wnl.56.1.8  0.665
2000 Racette BA, Rich KM, Randle J, Mink JW. Ipsilateral thalamic stimulation after thalamotomy for essential tremor. A case report. Stereotactic and Functional Neurosurgery. 75: 155-9. PMID 11910208 DOI: 10.1159/000048400  0.559
2000 Black KJ, Mink JW. Response to levodopa challenge in Tourette syndrome. Movement Disorders : Official Journal of the Movement Disorder Society. 15: 1194-8. PMID 11104204 DOI: 10.1002/1531-8257(200011)15:6<1194::Aid-Mds1019>3.0.Co;2-H  0.562
2000 Brunstrom JE, Bastian AJ, Wong M, Mink JW. Motor benefit from levodopa in spastic quadriplegic cerebral palsy. Annals of Neurology. 47: 662-5. PMID 10805341 DOI: 10.1002/1531-8249(200005)47:5<662::AID-ANA18>3.0.CO;2-U  0.524
2000 Racette BA, Rich KM, Randle J, Mink JW, Goto S, Hamasaki T, Nishikawa S, Okamura A, Yoshikawa M, Yamada K, Soyama N, Mita S, Ushio Y, Steinmeier R, Rachinger J, et al. Contents Vol. 75, 2000 Stereotactic and Functional Neurosurgery. 75: 205-205. DOI: 10.1159/000048408  0.495
2000 Racette BA, Rich KM, Randle J, Mink JW, Goto S, Hamasaki T, Nishikawa S, Okamura A, Yoshikawa M, Yamada K, Soyama N, Mita S, Ushio Y, Steinmeier R, Rachinger J, et al. Subject Index Vol. 75, 2000 Stereotactic and Functional Neurosurgery. 75: 204-204. DOI: 10.1159/000048407  0.514
1999 Wenger KK, Musch KL, Mink JW. Impaired reaching and grasping after focal inactivation of globus pallidus pars interna in the monkey. Journal of Neurophysiology. 82: 2049-60. PMID 10561386 DOI: 10.1152/Jn.1999.82.5.2049  0.303
1999 Black KJ, Mink JW. Neuropsychiatry of movement disorders Current Opinion in Psychiatry. 12: 313-319. DOI: 10.1097/00001504-199905000-00011  0.561
1998 Bastian AJ, Mink JW, Kaufman BA, Thach WT. Posterior vermal split syndrome. Annals of Neurology. 44: 601-10. PMID 9778258 DOI: 10.1002/Ana.410440405  0.716
1996 Mink JW. The basal ganglia: focused selection and inhibition of competing motor programs. Progress in Neurobiology. 50: 381-425. PMID 9004351 DOI: 10.1016/S0301-0082(96)00042-1  0.325
1993 Mink JW, Thach WT. Basal ganglia intrinsic circuits and their role in behavior. Current Opinion in Neurobiology. 3: 950-7. PMID 8124079 DOI: 10.1016/0959-4388(93)90167-W  0.634
1991 Mink JW, Thach WT. Basal ganglia motor control. III. Pallidal ablation: normal reaction time, muscle cocontraction, and slow movement. Journal of Neurophysiology. 65: 330-51. PMID 2016644 DOI: 10.1152/Jn.1991.65.2.330  0.64
1991 Mink JW, Thach WT. Basal ganglia motor control. II. Late pallidal timing relative to movement onset and inconsistent pallidal coding of movement parameters. Journal of Neurophysiology. 65: 301-29. PMID 2016643 DOI: 10.1152/Jn.1991.65.2.301  0.642
1991 Mink JW, Thach WT. Basal ganglia motor control. I. Nonexclusive relation of pallidal discharge to five movement modes. Journal of Neurophysiology. 65: 273-300. PMID 2016642 DOI: 10.1152/Jn.1991.65.2.273  0.617
1987 Mink JW, Thach WT. Preferential relation of pallidal neurons to ballistic movements. Brain Research. 417: 393-8. PMID 3651822 DOI: 10.1016/0006-8993(87)90472-0  0.632
1986 Thach WT, Schieber MH, Mink J, Kane S, Horne M. Cerebellar relation to muscle spindles in hand tracking. Progress in Brain Research. 64: 217-24. PMID 2941819 DOI: 10.1016/S0079-6123(08)63416-0  0.72
1983 Mink JW, Sinnamon HM, Adams DB. Activity of basal forebrain neurons in the rat during motivated behaviors. Behavioural Brain Research. 8: 85-108. PMID 6849681 DOI: 10.1016/0166-4328(83)90173-0  0.655
Show low-probability matches.